Efficacy of Tranexamic Acid in Reducing the Blood Loss During Cesarean Section in Primigravida Patients with Breech Presentation

OBJECTIVES: The objective of the study was to evaluate the efficacy of tranexamic acid in decreasing blood loss at the caesarian section (CS). METHODOLOGY: A descriptive case series study was conducted in the Department of Obstetrics and Gynecology, Lady Reading Hospital, Peshawar, Pakistan. Data were collected from September 24, 2018, to March 24, 2019. A total of 114 term women (18-35 years age) with singleton term breech cases were analyzed for a period of six months RESULTS: In this study the mean age was 30 years with SD±2.341 and the mean period of gestation was 38 weeks with SD±4.76. Moreover, tranexamic acid was effective in 91% of patients and was not effective in 9% of patients. CONCLUSION: Our study concludes that the efficacy of tranexamic acid was 91% in reducing the blood loss during CS in primigravida patients with breech presentation.